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Background: Older adults are at greatest risk of medication errors during the transition period of the 
first 7 days after admission and readmission to a skilled nursing facility (SNF).
Purpose: The aim of this study was to evaluate structure- and process-related factors that 
contribute to medication errors and harm during transition periods at a SNF.
Methodology/Approach: Data for medication errors and potential medication errors during the 7-
day transition period for residents entering North Carolina SNFs were from the Medication Error 
Quality InitiativeVIndividual Error database from October 2006 to September 2007. The impact of 
SNF structure and process measures on the number of reported medication errors and harm from 
errors were examined using bivariate and multivariate model methods. Findings: A total of 138 SNFs 
reported 581 transition period medication errors; 73 (12.6%) caused harm. Chain affiliation was 
associated with a reduction in the volume of errors during the transition period. One third of all reported 
transition errors occurred during the medication administration phase of the medication use process, 
where dose omissions were the most common type of error; however, dose omissions caused harm 
less often than wrong-dose errors did. Prescribing errors were much less common than 
administration errors but were much more likely to cause harm. Practice Implications: Both structure 
and process measures of quality were related to the volume of medication errors.
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Older adults are especially susceptible to adverse drug 
events and medication errors due to frailty, multiple 
physical and cognitive ailments, complex
drug regimens, and frequent interactions with multiple
health care providers. The National Coordinating Council
for Medication Error Reporting and Prevention (NCC-
MERP; 2012) defines amedication error as ‘‘any preventable
events that may cause or lead to inappropriate medication
use or patient harmwhile themedication is in control of the
health care professional, patient, or consumer’’ (paragraph 1).
An adverse drug event (ADE) is a potential consequence of
a medication error and is defined as ‘‘an injury resulting
from the medical intervention related to a drug’’ (Bates
et al., 1995, p. 30); an ADEmay have resulted from ‘‘medi-
cation errors (i.e., errors in prescribing, dispensing, adminis-
tration, and monitoring) or from adverse drug reactions in
which no error was involved’’ (Gurwitz et al., 2000, p. 88).
The Institute of Medicine (IOM) reported that medication
errors contribute to 1.5 millionADEs annually (Aspenden,
Wolcott, Bootman, & Cronenwett, 2006). Approximately
half of all ADEs requiring hospitalization were for in-
dividuals 65 years or older (Budnitz et al., 2006). For many
older adults in skilled nursing facilities (SNFs), an ADE
contributes to a downward cascade in health (Gurwitz
et al., 2000).
Approximately 800,000 preventable ADEs occur in
U.S. long-term care facilities annually, with an estimated
350,000 in SNFs (Gurwitz et al., 2005). In North Carolina,
from 2005 to 2008, SNFs reported 12,993Y16,106 medi-
cation errors and potential medication errors combined
annually (circumstances or events that have the capacity
to cause an error) (Hartwig, Denger, & Schneider, 1991;
Williams et al., 2008).
Studies of medication-related errors and ADEs in SNFs
have found that residents are at greatest risk of medica-
tion errors during care transition periods such as admission
and readmission to the nursing home after a hospitaliza-
tion (Desai, Williams, Greene, Pierson, & Hansen, 2011;
Pronovost et al., 2003). Nearly half of all medication errors
occur during transitions between levels of care or providers,
a time when orders are frequently updated and changed
(Bates et al., 1997).Medication errors during transitions are
primarily due to poor communication between care teams
(Aspenden et al., 2006). Understanding the medication
use risk factors during transition into SNFs may improve
safety during transitions and contribute to reductions in
hospital readmissions. The Patient Protection and Afford-
able Care Act encourages communication between pro-
viders and safer patient transitions through prohibiting
reimbursement to hospitals for patients readmitted within
30 days.Withmany SNF residents admitted fromhospitals,
an improved understanding of medication use risk factors
could be utilized to improve communication processes, re-
duce inaccurate documentation, and help to reduce hospital
readmissions.
Although some research on the transition period for
SNF residents is available, little is known about the in-
terplay between errors and specific facility structure and
process attributes thatmay contribute to the volume of errors
and to harm from errors. The objective of this study was to
identify structure and process quality measures that con-
tribute to the number of medication errors reported and
their harm during the transition period into SNFs.
Background and Conceptual 
Framework
Donabedian’s (1966) frequently cited framework for ana-
lyzing quality in health care settings suggests that both
structure and process measures may play a key role in ex-
plaining the occurrence of medication errors and the like-
lihood of harm from those errors.
Studies have evaluated relationships between structural
variables such as ownership (Castle, 2000; Konetzka, Spector,
& Shaffer, 2004; O’Neill, Harrington, Kitchener, & Saliba,
2003; Zinn, Spector, Hsieeh, & Mukamel, 2005), chain
membership (Castle, 2000; Konetzka et al., 2004; O’Neill
et al., 2003; Zinn et al., 2005), size (Castle, 2000; O’Neill
et al., 2003; Zinn et al., 2005), and location (Bowblis,
Meng, & Hyer, 2013; Hutchinson, Hawes, & Williams
2005; Phillips, Holan, Sherman,Williams, &Hawes, 2004)
and quality-oriented outcomes, with varying results. For-
profit long-term care facilities were found to hospitalize
their residents suspected of pneumonia 2 times more often
than not-for-profit facilities (Konetzka et al., 2004), in-
crease restraint use by 20% (Castle, 2000), have 1.2 times
more survey deficiencies, and have a higher total (25%)
number of F-plus survey deficiencies (O’Neill et al., 2003)
(defined as potential or actual harmoccurred for at least one
resident) than not-for-profit facilities. Chain ownership was
found to increase restraint use (31% increase) (Castle, 2000)
and number of survey deficiencies (Amirkhanyan, Kim, &
Lambright, 2008; O’Neill et al., 2003). Facility size produced
varying effects in differences in outcomes. For example, re-
straint use decreased by 5% for every 10-bed increase in
nursing home size (Castle, 2000), whereas number of beds
was not determined to contribute to higher numbers of
deficiencies or F-plus deficiencies (O’Neill et al., 2003).
Amirkhanyan et al. (2008) reported that as number of beds
increased, for-profit facilities had significantly more defi-
ciencies. Studies of facility location found nonurban nursing
homes to have lower staffing ratios (Hutchinson et al., 2005)
and more residents with acquired contractures (Bowblis
et al., 2013) and higher risks of urinary tract infection and
pressure ulcers (Phillips et al., 2004) than residents in urban
nursing homes. Previous research on profit status and qual-
ity of resident care indicates that poorer quality of care
occurs in for-profit SNFs (Castle&Engberg, 2008; Intrator,
Zinn, &Mor, 2004). However, no study has considered the
effect of these structure measures on the volume of self-
reported medication errors and harm frommedication errors
during the 7-day transition into an SNF.
Research on the processes that have the largest impact
on the volume of medication errors in SNFs considers a
variety of processes and often includes studies of ADEs. For
example, studies of medication use processes indicate that
ADEs occurred most often during the monitoring phase
and medication errors occurred most often during the ad-
ministering phase of the process (Desai et al., 2011; Gurwitz
et al., 2000, 2005; Williams et al., 2008). Studies of the
types of errors vary with respect to the definitions used to
categorize the error types. For example, studies defining
wrong dose as overdose, underdose, or dose omission often
report wrong dose as the most frequent type of error re-
ported, ranging from 48% to 65% of the reported errors
(Crespin et al., 2010; Desai et al., 2011; Gurwitz et al.,
2005). In contrast, studies categorizing dose omission sep-
arately from overdose and underdose report that dose
omissions occurred more frequently than wrong-dose errors
(Barker, Flynn, Pepper, Bates, & Mikeal, 2002; Williams
et al., 2008). Research focusing on processes of care to assess
medication errors reported during the 7 days of transition
into the SNF is limited.
In addition to assessing the frequency of medication
errors and processes contributing to the volume of errors, it
is also useful to examine if harm occurred. One study of
changes in medication orders for patients transitioning
from a nursing home to a hospital and back to a nursing
home reported that 8% of the bidirectional transfers ex-
perienced an ADE attributable to medication changes
upon readmission to the SNF (Boockvar et al., 2004). Desai
et al. (2011) examined medication errors during transition
into the SNF and found that 1.5% of the errors occurring
during the 7-day transition into the SNF caused harm,
whereas harm occurred in only 0.7% of non-transition-
period errors. We used a subset of the data that Desai et al.
used in their study and focused only on those medication
errors thatwere reported as occurring during transition.Our
research extends their work and assesses the SNF structure
and medication use process factors that could exacerbate
the risk of harmful medication errors.
Conceptual Framework
On the basis of the previous nursing home research using
theDonabedian framework, we hypothesized the following:
1) For-profit, larger, nonurban, chain-affiliated nursing
homes will have a higher rate of medication errors
during the 7 days after admission thanwill not-for-profit,
smaller, urban, non-chain-affiliated nursing homes.
2) Medication errors in for-profit, larger, nonurban, and
chain-affiliated nursing homes are more likely to be
harmful than medication errors during the 7 days after
admission innot-for-profit, smaller, urban, andnon-chain-
affiliated nursing homes.
3) Medication errors are more likely to be harmful during
the 7 days after admission when administering is reported
as the medication use phase compared with any other
phase in the medication use process.
4) Medication errors are more likely to be harmful during
the 7 days after admissionwhenwrong dose is reported as
the error type compared with any other type of error.
Hypotheses 1 and 2 consider the impact of the structure
quality measures on the volume of medication errors and
the probability of harm from a medication error. Hypoth-
eses 3 and 4 consider the impact of process quality measures
related to medication errors that might influence the prob-
ability that a resident is harmed when a medication error
occurs. These include the phase of the drug delivery process
in which the error occurs, the type of medication error, the
underlying cause of the error, and the personnel involved in
the error. In this study, type of medication error refers to the
mistake made in the medication use process, whereas the
phase of the medication use process refers to the timing
of the error in the prescribing through postadministration
phases of medication delivery. For example, ‘‘wrong dose’’ is
a type of medication error where the correct medication is
given to the correct resident at the correct time but in the
wrong dose. A wrong-dose error may occur at several points
in the medication use process; for instance, the wrong dose
may occur due to a prescribing error or an administering error.
Methods
Study Design and Data
The Medication Error Quality Initiative (MEQI) data for
North Carolina nursing homes was used. Medication Error
Quality Initiative data are statutorily mandated self-reported
medication errors and potential errors for all SNFs licensed
in North Carolina. Reporting Year 4 (October 1, 2006Y
September 30, 2007) provided the option to report errors
using the individual error (IE) reporting or annual report-
ing system: 203 of the 393 SNFs opted to use the Web-
based IE system (Williams et al., 2008). Crespin et al.
(2010) indicate no evidence of differences in characteris-
tics of errors reported by facilities using the aggregated
annual system and those using the IE reporting system for
reporting Year 4 in North Carolina. Because the focus of
our study was the 7-day transition period, we included
only those medication errors reported as occurring during
the first 7 days of admission. The dataset contained only
non-government-owned SNFs (i.e., not-for-profit and for-
profit SNFs). Each facility in our dataset participated for
the entire reporting year.
TheMEQI-IE data allowed us to assess medication-error-
related outcomes at the facility level (i.e., the number and
type of medication errors by facility) and error report level
(each reported medication error or potential medication
error). The dichotomous variable indicating whether the
resident was harmed by the medication error (1) or not
(0) was constructed from the nine possible error impact
categories established by NCC-MERP, of which six cate-
gories occur in the data during the 7-day transition period.
The categories capacity to cause error (no resident in-
volved; 1.2% of the errors during the 7-day transition
period), error did not reach resident (7.8%), and error
reached the resident but did not cause harm (78.5%)
were categorized as no harm. The categories of required
monitoring/intervention to preclude harm (10.3% of the
errors during the 7-day transition period), temporary harm
to resident (1.6%), and temporary harm to resident with
trip to emergency room (0.7%) were categorized as caus-
ing harm. This categorization was also used by the Sheps
Center researchers in preparing the annual MEQI reports.
Factors likely to affect outcomes include structure var-
iables, process variables, and resident characteristics. Struc-
ture variables were ownership (for-profit, not-for-profit),
size (number of beds), location (nonurban, urban), and
whether the facility is part of a chain of nursing homes.
Process variables were type ofmedication error, phase in the
medication use process, personnel involved in the error,
and the reported causes of the errors. In addition, the mul-
tivariate analysis of harm from an error included controls
for resident characteristics as reported by the SNF in the
MEQI-IE report; these included age, gender, whether res-
idents were able to direct their own care, and number of
medications taken per day.
We aggregated types of errors into seven categories to
have sufficient numbers for meaningful analysis in each
category: wrong patient, wrong drug, dose omission, wrong
dose (referent), wrong administration, wrong follow-up,
and other type of error. Phases in the medication use pro-
cess were prescribing, dispensing, documenting, adminis-
tering (referent), and monitoring. Possible causes of errors
were also collapsed into the six categories of causes: product
issues, recording issues, dispensing issues, facility issues,
personnel issues, or other causes, wheremultiple causes may
be present for each error. The MEQI-IE allows for multiple
selections for reporting the possible causes or reasons for
the error or potential error; therefore, the categories are
not mutually exclusive. Personnel involved in the error were
collapsed into two categories: licensed practical nurse (LPN)
and all other non-LPN staff (e.g., registered nurses, medi-
cation aides, physicians, pharmacists, and so forth).
We acknowledge several limitations of our data use
agreement: These data were limited to the first 7 days of
admission and do not identify on which of the first 7 days
the error occurred or where the resident was admitted from.
We could not examine care transition periods of differing
lengths, resident acuity, or whether the error was repeated.
Data Analysis
The dataset contained 581 errors reported by 138 SNFs
during the 7 days after admission or readmission to an SNF
from the 203 SNFs in the MEQI-IE database. One facility
had an incorrectly coded variable, resulting in 137 SNFs
used in the facility-level analysis, and seven reported errors
had missing values for one or more resident characteristics,
resulting in 574 observations used in the error-report-level
analysis described below.
Two sets of results are presented. The first set of results
considers the impact of SNF structure quality measures
on the number of medication errors at the facility level.
Descriptive statistics of the facility-level medication error
counts over the 1-year period were computed using the 138
facilities; next, medication error counts were modeled as a
function of facility structural attributes for the 137 SNFs
with complete data using negative binomial regression mod-
els. Two models were estimated; results are reported for
models with and without an interaction between owner-
ship type and chain affiliation. Incidence rate ratio (IRR)
estimates for each structural explanatory variable are pres-
ented. The second set of results contains descriptive sta-
tistics based on all 581 medication errors, where bivariate
tests for statistically significant differences in the propor-
tion of errors causing harm were conducted. Given that it
is likely that there are relationships among the various
structural and process measures included as explanatory
variables in our models, explanatory variables were assessed
for multicollinearity by considering the variance inflation
factor (VIF) for each independent variable using linear
regression analysis; the VIF was found to be less than 2.5 in
all cases. In a linear probabilitymodel, VIF values above 2.5
indicate likely multicollinearity (Allison, 1999). Next, two
multivariate logistic regression models were estimated to
examine the probability that a specificmedication error was
harmful using the 574 observations with complete data on
resident characteristics. Model 1 includes all explanatory
variables except the resident’s number of medications for
the 574 observations with complete data. Model 2 includes
the number of medications; the 332 records with missing
medications also had missing values for age, gender, and
able to direct their own care observations, reducing the
estimation sample from 581 to 249. Analyses were con-
ducted using SAS Version 9.1 (Cary, NC).
Findings
Facility-Level Analysis: Volume of
Medication Errors
As shown in Table 1, of the 203 SNFs that reported
medication errors using the IE system (MEQI-IE), 138
(67.9%) reported at least one medication error, and these
reporting facilities had, on average, four errors during the
first 7 days of a resident’s admission. The average facility size
was 120 beds, 62% of the facilities had 101 beds or more,
72% were for-profit, 68% were part of a chain, and 62%
were located in an urban area.
Results of two negative binomial regression models
of the number of medication error reports per facility are
presented in Table 2. Model 1 includes the binary in-
dicators for ownership and chain affiliation as separate
covariates. Model 2 includes interactions between owner-
ship status and chain affiliation. In Model 1, the rate at
which medication errors occurred for chain-affiliated SNFs
was approximately two thirds the rate of medication errors
found in non-chain-affiliated SNFs (IRR = 0.67; 95%
confidence interval [CI] [0.48, 0.92]). Model 2 shows that
the rate at which medication errors occurred in chain-
affiliated for-profit SNFs was less than the rate of errors in
non-chain-affiliated for-profit SNFs (IRR = 0.68; 95% CI
[0.45, 1.01]). In both models, SNFs with more than 151
beds had more than 2 times the rate of medication errors
(Model 1, IRR = 2.12; Model 2, IRR = 2.11) found in
SNFs with 100 beds or less.
Medication Error Report Level: Harm From
Medication Errors
Descriptive statistics at the error level are shown inTable 3.
During the 7-day transition period, 581 errors were re-
ported, of which 73 (13%) caused harm. Examining struc-
ture factors first, 405 (70%) of the errors were reported by
for-profit SNFs and 339 (58%) were from chain-affiliated
facilities; 61% of the reported errors were from SNFs lo-
cated in an urban area; and nearly half of all errors were in
facilities with 101Y150 beds. In terms of process factors, the
most commonly cited cause of errors was personnel issues
(65%), followed by recording issues (39%). The most com-
mon types of medication errors were dose omission (36%)
and wrong dose (20%).When considering the phase in the
medication use process, errors occurred most often in the
documenting phase (47%), followed by errors in adminis-
tration of medication (33%). Only 4.8% of all errors in the
transition period occurred in the prescribing phase. Finally,
nearly two thirds of all errors involved an LPN. Turning to
resident characteristics, residents experiencing medication
errors were predominately women (66%), had an average
age of 78 years, were likely to be unable to direct their own
care (65%), and were taking an average of 12 medications.
For the binary variables, Table 3 shows the p values for
chi-square tests of significant differences in the proportion
of errors causing harm. For continuous variables, t tests ex-
amined differences between the mean values of harmful
versus nonharmful medication errors. For structure factors,
a statistically significant difference (p e .05) in the pro-
portion of errors causing harm is found only for facility
location, where an error in an urban SNF is significantly
more likely to be harmful than an error in a nonurban SNF.
For process factors, there were no statistically significant
differences in the probability of harm for each of the causes
of errors and for the types of errors (with wrong dose as the
reference category for the type of error). In the phases of
the medication use process, although documenting errors
represented 47% of all errors, they only represented 36% of
Table 1
Skilled nursing facility (SNF) 7-day transition 
error volume and structure factors
Total
n %
Total SNFs 137a 100
Ownership
Not-for-profit 39 28.5
For-profit 98 71.5
Affiliated with chain
No 44 32.1
Yes 93 67.9
Number of beds
M (SD) 120 (40.4)
G100 51 37.0
101Y150 60 43.5
9151 26 18.8
Facility location
Urban 85 62.0
Nonurban 52 38.0
Medication errors per SNF 4.21
Medication errors per 100 beds 3.59
Note. Data source: North Carolina Medication Error Quality
InitiativeVIndividual Error reporting system year 4, October 1,
2006YSeptember 30, 2007.
aAn error for one SNF reduced the analytical sample from 138 to
137 SNFs.
harmful errors. In contrast, prescribing errors were over-
represented among harmful errors; they were only 4.8% of
all errors but 18% of harmful errors. Errors involving LPNs
were significantly less likely to cause harm than errors
involving non-LPN staff. For resident characteristics, the
average resident age was significantly lower for errors
causing harm.
Table 4 shows the results of the multivariate analysis of
the probability that a medication error caused harm. None
of the structure factors were significant predictors of harm
from a medication error. Of the process measures, none of
the causes of errors were significant predictors of harm. In
Model 1, which does not control for number ofmedications
taken by a resident, the odds ratios (ORs) on all of the
indicators for the type of error to cause harm were less than
1, which suggests that the reference wrong-dose error is
more likely to cause harm than other error types. For
example, dose omission errors were less likely to cause harm
(OR = 0.45, 95% CI [0.23, 0.89]) than wrong-dose errors.
When considering the phase in the medication use process
in which the error occurred, in Model 1, the adjusted odds
that a medication error was harmful were significantly
higher for prescribing errors when compared with admin-
istering errors (OR = 8.6, 95%CI [3.03, 24.35]). In Model 2,
which controls for the number of medications taken
by the resident, compared with wrong-dose errors, errors
involving the wrong patient are less likely to cause harm
(OR = 0.09, 95% CI [0.01, 0.71]), whereas other types of
errors are more likely to cause harm. Considering the phase
of the medication use process, errors reported during the
monitoring phase were less likely to cause harm than
administering errors (OR = 0.34, 95%CI [0.13, 0.94]). Of
the resident characteristics, age was statistically significant
in Model 2, although only slightly greater than 1 (OR =
1.06, 95%CI [1.01, 1.10]) of the probability of harm from a
medication error.
Discussion
This study examined the facility-reported medication error
reports for medication errors and potential medication
errors that occurred during the 7-day transition period for
residents entering or reentering an SNF, a time when
Table 2
Facility-level analysis of the number of medication errors reported during the 7 days 
of transition into the skilled nursing facility
Model 1 Model 2
Variable/Category IRRa 95% CI IRR 95% CI
Ownership
Not-for-profit (ref)
For-profit 1.12 [0.80, 1.59]
Affiliated with a chain
No (ref)
Yes 0.67* [0.48, 0.92]
Interaction
For-profit and not chain affiliated (ref)
Not-for-profit and chain affiliated 0.59 [0.33, 1.04]
For-profit and chain affiliated 0.68 [0.45, 1.01]
Not-for-profit and not chain affiliated 0.91 [0.55, 1.48]
Location
Nonurban (ref)
Urban 0.97 [0.73, 1.30] 0.97 [0.73, 1.30]
Bed size
e100 (ref)
101Y150 1.64* [1.18, 2.26] 1.64* [1.18, 2.26]
Q151 2.12* [1.44, 3.13] 2.11* [1.43, 3.12]
Number of observations 137 137
Note. Data source: North Carolina Medication Error Quality InitiativeVIndividual Error reporting system, year 4, October 1, 2006YSeptember
30, 2007. Model 1 includes no interaction between ownership and chain-affiliation. Model 2 includes an interaction between ownership and
chain-affiliation. IRR = incidence rate ratio; CI = confidence interval.
aAdjusted IRRs were estimated using negative binomial regression models.
*p G .05.
Table 3
Error-level bivariate analysis of structure factors, process factors, and resident characteristics 
by whether a medication error caused harm
No harm Harm Total
n % o r M n % o r M n % o r M p
Structure factors
Ownership
Not-for profit (ref) 151 29.7% 25 34.2% 176 30.3%
For-profit 357 70.3% 48 65.8% 405 69.7% .43
Affiliated with chain
No (ref) 209 41.1% 33 45.2% 242 41.7%
Yes 299 58.9% 40 54.8% 339 58.3% .51
Number of beds
G100 (ref) 120 23.6% 22 30.1% 142 24.4%
101Y150 250 49.2% 33 45.2% 283 48.7% .27
9151 138 27.2% 18 24.7% 156 26.9% .32
Facility location
Urban (ref) 300 59.1% 54 74.0% 354 60.9%
Nonurban 208 40.9% 19 26.0% 227 39.1% .01
Process factors
Causes of errorsa
Product issue 24 4.7% 5 6.8% 29 4.99% .44
Recording issue 200 39.4% 28 38.4% 228 39.24% .87
Dispensing 54 10.6% 7 9.6% 61 10.50% .79
Facility issue 61 12.0% 13 17.8% 74 12.74% .16
Personnel issue 339 66.7% 41 56.2% 380 65.40% .08
Other causes 28 5.5% 6 8.2% 34 5.85% .36
Total causes 706 100 806
Types of medication errors
Wrong dose (ref) 93 18.3% 24 32.9% 117 20.14%
Wrong patient 17 3.3% 4 5.5% 21 3.61% .36
Dose omission 189 37.2% 22 30.1% 211 36.32% .24
Wrong administration 48 9.4% 3 4.1% 51 8.78% .13
Wrong follow-up 47 9.3% 5 6.8% 52 8.95% .5
Other 45 8.9% 6 8.2% 51 8.78% .86
Medication use process
Administering (ref) 172 33.9% 22 30.1% 194 33.4%
Prescribing 15 3.0% 13 17.8% 28 4.8% .00
Dispensing 68 13.4% 10 13.7% 78 13.4% .94
Documenting 245 48.2% 26 35.6% 271 46.6% .04
Monitoring 8 1.6% 2 2.7% 10 1.7% .47
Personnel involved
LPN 334 65.7% 39 53.4% 373 64.2%
All other non-LPN (ref) 174 34.3% 34 46.6% 208 35.8% .04
Resident characteristics
Resident ageb 501 78.21 73 74.34 574 77.72 .008
Resident genderb
Male (ref) 171 34.1% 26 35.6% 197 34.3%
Female 330 65.9% 47 64.4% 377 65.7% .80
Resident able to direct own careb
Yes 173 34.5% 28 38.4% 201 35.0%
No (ref) 328 65.5% 45 61.6% 373 65.0% .81
Number of medicationsc 218 12.01 31 12.29 249 12.05 .74
Total number of errors 508 87.4% 73 12.6% 581 100.0%
Note. Data source: North Carolina Medication Error Quality InitiativeVIndividual Error reporting system, year 4, October 1, 2006YSeptember
30, 2007. Chi-square tests for group differences in the proportion of errors that were harmful were conducted for each of the categorical
variables. Similarly, t tests were used for continuous measures. LPN = licensed practical nurse.
aCauses of errors are not mutually exclusive because selection of multiple causes was allowed.
bData were missing for seven observations.
cNumber of medications is computed for residents with reported medications not missing and greater than zero.
medication orders are often updated to reflect the acuity
level of the resident at the time of transfer. The first two
hypotheses focused on structure-related medication errors.
Regarding Hypothesis 1, our findings did not support any
differences in errors for nonurban or for-profit facilities. As
expected, we found that larger facilities have higher error
rates. In addition, our results suggest that chain affiliation
reduces the volume of errors during the 7-day transition
period. Assuming equivalent statutory compliance in er-
ror reporting by chain-affiliated and non-chain-affiliated
SNFs, this finding suggests that processes in chains may
provide a protective effect against medication errors.
Table 4
Multivariate analysis of the probability that a medication error caused harm
Model 1 Model 2
Odds ratio 95% CI Odds ratio 95% CI
Structure factors
Facility ownership (reference: NFP and not chain affiliated)
NFP and chain affiliated 0.41 [0.10, 1.69] 0.13 [0.02, 1.05]
FP and not chain affiliated 0.76 [0.27, 2.12] 0.67 [0.14, 3.12]
FP and chain affiliated 1.02 [0.50, 2.06] 0.76 [0.23, 2.51]
Location (reference: urban)
Nonurban 1.86 [0.99, 3.52] 2.27 [0.99, 5.21]
Number of beds (reference: G100)
101Y150 0.69 [0.38, 1.24] 1.19 [0.45, 3.16]
Q151 0.49 [0.23, 1.03] 1.04 [0.28, 3.88]
Process factors
Causes of errors (reference: no cause reported)
Product issue 1.42 [0.48, 4.15] 0.21 [0.03, 1.38]
Recording issue 0.78 [0.34, 1.79] 1.52 [0.32, 7.12]
Dispensing 0.51 [0.21, 1.23] 0.53 [0.12, 2.39]
Facility issue 1.94 [0.91, 4.14] 2.18 [0.53, 9.03]
Personnel issue 0.50 [0.24, 1.04] 0.41 [0.12, 1.37]
Other causes 1.40 [0.45, 4.34] 1.75 [0.25, 12.52]
Type of medication error (reference: wrong dose)
Wrong patient 0.74 [0.20, 2.80] 0.09* [0.01, 0.71]
Wrong drug 0.64 [0.26, 1.57] 0.10 [0.01, 1.87]
Dose omission 0.45* [0.23, 0.89] 1.63 [0.42, 6.37]
Wrong administration 0.30 [0.08, 1.09] 0.88 [0.26, 2.94]
Wrong follow-up 0.43 [0.14, 1.35] 32.40 [0.85, 9999.99]
Other type of error 0.40 [0.14, 1.09] 13.96* [1.92, 101.68]
Medication use process (reference: administering)
Dispensing 1.20 [0.47, 3.08] 3.34 [0.15, 73.85]
Documenting 0.97 [0.47, 2.01] 1.72 [0.47, 6.34]
Monitoring 4.17 [0.50, 34.89] 0.34* [0.13, 0.94]
Prescribing 8.59* [3.03, 24.35] 0.13 [0.01, 2.16]
Personnel involved (reference: LPN)
All other non-LPN 0.68 [0.39, 1.20] 2.02 [0.69, 5.91]
Resident characteristics
Gender (reference: male)
Female 0.84 [0.49, 1.46] 0.43 [0.15, 1.24]
Age 0.98 [0.96, 1.00] 1.06* [1.01, 1.10]
Patient able to direct own care (reference: able to direct own care)
No 1.11 [0.61, 2.02] 0.98 [0.38, 2.53]
Number of medications 1.02 [0.93, 1.13]
Number of observations 581 249
Note. Data source: North Carolina Medication Error Quality InitiativeVIndividual Error reporting system, year 4, October 1, 2006YSeptember
30, 2007. We also estimated models without the interactions, and the resulting odds ratios were not statistically significant. Model 1 does not
include number of medications, whereas Model 2 includes number of medications. All standard errors are adjusted for clustering within the
skilled nursing facility. CI = confidence interval; NFP = not-for-profit; FP = for-profit; LPN, licensed practical nurse.
*p e .05.
Edmondson’s (2004) work on organizational learning sug-
gests that interpersonal climate and organizational culture
can contribute to openness and willingness to discuss errors
and near-misses; this may contribute to the differences in
the reported errors between SNFs.
We did not find a difference in reported medication
errors or harmful medication errors between urban SNFs
and nonurban SNFs. This result could be attributable to the
small sample size (581 errors), limited timeframe (1 year),
and use of a dichotomous categorization for this variable.
Bowblis et al. (2013) used four categories of location over a
10-year period and observed differences between urban and
isolated SNFs in residents acquiring contractures. Kang,
Meng, and Miller (2011) reported that residents in rural
SNFs were 1.5 times more likely to be hospitalized after
admission and havemoderate or severe pain comparedwith
residents in urban SNFs. With these factors and the lower
staffing ratios reported in rural SNFs, differences between
urban and nonurban SNF medication error reporting rates
deserve further study.
Our findings differ from previous studies that found
that chain affiliation contributed to poorer quality care
(Amirkhanyan et al., 2008; Harrington, Woolhandler,
Mullan, Carillo, & Himmelstein, 2001). An alternative
possibility that would support previous research would be
that chain-affiliated facilities may have corporate cultures
and policies that inadvertently create barriers to reporting
medication errors through actions such as narrow inter-
pretations of what defines a medication error, fear of legal
liability, use of incident reports to monitor liability not
improve patient care, or lack of a uniform standard for what
kinds of errors are reported by SNFs (Barach, 2003;Mayo&
Duncan, 2004;Williams et al., 2011). These organizational
cultures and corporate policies may lead to differences in
the volume of error reports from non-chain-affiliated SNFs.
Future research to better inform our understanding of
chain affiliation and its impact on medication error report-
ing could be conducted with focus groups or structured
interviews of nurses in chain-affiliated (both for-profit
and not-for-profit) and non-chain-affiliated (both for-
profit and not-for-profit) SNFs, examining barriers and
enablers of reporting errors. Hypothesis 2 was also not sup-
ported. No significant relationships were found between
the probability that an error caused harm and structure
factors when controlling for process quality measures and
resident characteristics.
The other two hypotheses focused on specific processes
and medication errors. Hypothesis 3, focusing on admin-
isteringmedications, was not supported; however, we found
a significant relationship between prescribing errors and
harm. Prescribing errors made up less than 5% of all er-
rors, yet these errors caused harm in nearly half of all
occurrences. In the multivariate analysis, prescribing errors
were 9 times more likely to cause harm during the transi-
tion period than were administering errors. This finding is
consistent with previous studies (Desai et al., 2011;Gurwitz
et al., 2000, 2005;Williams et al., 2008). Findings from the
present study indicate that prescribing errors are the most
pressing medication error problem for residents during the
transition period into the SNF. Prescribing of medications
often occurs during transition and thus contributes to its
increased risk during this time. Causes of prescribing errors
during transition are often attributable to transcription er-
rors and poor communication.
Examining Hypothesis 4, we found wrong-dose errors to
bemore likely to be harmful than other types of medication
errors. Findings from our study suggest that dose omission is
the most likely medication error type during entry or re-
entry into the SNF, yet wrong dose contributed the most
harm. These results are consistent with other studies
(Boockvar et al., 2004; Desai et al., 2011; Leape et al.,
1995). Factors contributing to wrong-dose errors include
miscalculation of the dose or incomplete or illegible pre-
scriptions (Gladstone, 1995;Wright, 2007). Dose omissions
often have other causes, such as inaccurate medication
history, unavailability of the drug, and errors in transcribing
medication information during transfer (Lizer & Brackbill,
2007; Pronovost et al., 2003). In our study, dose-omission
errors were less harmful than wrong-dose errors.
Structure measures of ownership status, chain affilia-
tion, number of beds, and location had no effect on the
probability that a medication error caused harm. Given
restrictions in the data use agreement, we considered only a
limited number of structural attributes. It would be useful
for future research to consider the impact of additional
structure factors, such as nursing and pharmacy staffing
levels, proportion of Medicaid residents, occupancy rates,
and market factors. However, with that caveat inmind, our
study suggests that the likelihood of harm from an error is
more strongly related to process measures than structure
measures of quality.
When interpreting findings from medication error anal-
ysis, it is important to discuss error reporting approaches,
mandatory versus voluntary, which differ with respect
to the perceived focus or use of the report. Using the
Donabedian framework to describe incident reports, an
outcomes-oriented approach describes an adverse event
and the resultant harm (i.e., The National Quality Form’s
list of Serious Reportable Sentinel Events in Healthcare
and The Joint Commission’s Reviewable Sentinel Events),
whereas a process-oriented approach encompasses near-
misses and variations in care with a perspective of sys-
tems improvement (i.e., MEDMARX is an Internet-based
voluntary medication error reporting system). The IOM’s
2011 report on health information technology and patient
safety suggests that incident reports should be voluntary and
used for system improvements and learning, not account-
ability or blame (Warden, 2011). Fear of reporting has
been identified as a significant barrier in incident report-
ing in health care organizations, including nursing homes
(Wagner, Castle, & Handler, 2013). Very few studies re-
port on medication errors from a mandatory error reporting
system; exceptions using the North Carolina MEQI data
are Desai et al., (2011), Crespin et al. (2010), andWilliams
et al. (2008). In contrast, Santell and Hicks (2005) used
MEDMARX, the voluntary reporting system, in their
studies of medication errors of hospitalized older adults.
Several study limitations should be considered when in-
terpreting these findings. The data were self-reported from
a mandatory reporting program in one state; compliance
rates are not known. Without a nationwide mandatory re-
porting system, states have developed various adverse event
reporting systems with little or no consistency between
states. As of 2007, TheNational Academy for State Health
Policy reported that 25 states and the District of Columbia
had adverse event reporting systems. Lack of a national
reporting strategy weakens the reporting consistency for
nursing home organizations with SNFs in multiple states
and clinicians who relocate to other states. Of the many
methods available to document medication errors, self-
report of an error or near-miss has been shown to identify
fewer errors than observation, which is a limitation of our
study and others using self-reported errors. Facilities self-
selected to report using the MEQI-IE Web-based reporting
system. Although there is no evidence to suggest that the
facilities differ from those using the annual reporting ap-
proach, it is possible that our nursing home sample is not
representative of all North Carolina nursing homes in
dimensions that matter for 7-day transition errors. The data
are cross-sectional. It may be useful for future research to
examine changes over time. Although we controlled for
some resident characteristics in our analysis, resident char-
acteristics such as disease burden and activity limitations
were not available; their impact on the probability of harm
from a medication error is not known. Finally, the MEQI
data could not be merged with any other data, which
limited the variables available for analysis.
Practice Implications
The findings from the present study indicate an opportunity
to improve resident safety and outcomes during the transi-
tion period through implementation of continuous pro-
cesses suchas team-based approacheswith shared responsibility,
close communication with the consultant pharmacist and
the care team,medication reconciliation, systematicmonitor-
ing process, and use of a standardized transfer form (LaMantia,
Scheunemann,Viera, Busby-Whitehead,&Hanson, 2010;
Marcum, Handler, Wright, & Hanlon, 2010; Steinman,
Handler, Gurwitz, Schiff, & Covinsky, 2011).
In addition, implementing systems such as computer
provider order entry and electronic medical record systems
may help to reduce harmful medication errors through
changes in the ordering, administering, and monitoring
processes. Effectiveness would be increased if the elec-
tronic systems had connectivity. Implementation of health
information technology may improve adverse event re-
porting through anonymous reporting systems or, more
importantly, an ‘‘adverse reporting system that is read-
ily available’’ for staff use (Handler et al., 2007; Warden,
2011).
Collectively, the findings of the present study point to
the importance of systems and policies to prevent med-
ication errors during the transition into the SNF, such as
careful transcription, medication reconciliation, pharma-
cists monitoring the appropriateness of and interactions
between medications, and communication between hos-
pitals and nursing homes at the time of transfer (Shah,
Burack, & Boockvar, 2009).
Conclusions
Our study finding of a lower volume of errors in chain-
affiliated SNFs suggest that the processes and mechanisms
utilized by these systems for medication error identification,
reporting, and reduction may differ from independent
facilities. Potential examples of process variations that may
be related to chain affiliation include training mandates,
nurse staffing levels, standardizedmedication review systems,
risk management reviews resulting in practice changes, and
error reporting cultures.
When examining individual errors, we found that the
probability that an error causes harm during the 7-day
transition period was unrelated to structure factors and res-
ident characteristics but was related to several different
process-related qualitymeasures. These findings support the
need for preventive processes to avoid harm such as admin-
istrative controls and barriers, communication between care
teams, computer provider order entry and electronic medi-
cal record systems, and physician and pharmacy review.
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